Newbury Pharmaceuticals Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Lars Minor
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.3yrs |
| CEO ownership | n/a |
| Management average tenure | 3.3yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO
Lars Minor (53 yo)
3.3yrs
Tenure
Mr. Lars Minor is Chief Executive Officer at Newbury Pharmaceuticals AB since 2021. He has long experience in the pharma industry and his previous position was Corporate Vice President for strategy and exe...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman | 4.3yrs | kr1.32m | 0.76% SEK 625.5k | |
| Chief Financial Officer | 3.3yrs | no data | no data | |
| Vice President of Sales & Marketing | 3.3yrs | kr601.85k | no data | |
| Chief Executive Officer | 3.3yrs | no data | no data |
3.3yrs
Average Tenure
49.5yo
Average Age
Experienced Management: NEWBRY's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman | 4.3yrs | kr1.32m | 0.76% SEK 625.5k | |
| Independent Director | 4.3yrs | no data | no data | |
| Director | 3.3yrs | no data | 1.12% SEK 925.8k | |
| Independent Director | 4.3yrs | no data | no data |
4.3yrs
Average Tenure
48yo
Average Age
Experienced Board: NEWBRY's board of directors are considered experienced (4.3 years average tenure).